Long- term outcome of paediatric patients with ANCA vasculitis

Table 3 Treatment summary

Patient	IV CP	Oral CP	IV MP	OSt	AZA/ MMF	Cy	Biologic Agents	PEX
1	+	-	-	+	+	-	-	-
2	+	+	-	+	+	+	-	-
3	+	-	+	+	+	-	Rituximab (x1)	9 cycles
4	-	-	-	+	+	+	-	-
5	-	+++	-	+	+	+	-	-
6	+	+	+	+	+	+	Rituximab (x2) Infliximab (x1) Campath (x1)	-
7	+	+	+	+	+	+	Rituximab (x4)	-
8	-	++	+	+	+	-	-	-

CP: Cyclophosphamide; MP: Methylprednisolone; OSt: Oral steroids; Cy: Cyclosporin; PEX: Plasma exchange
NB: '+' represents a single course of cyclophosphamide in the Oral Cyclophosphamide column

ISSN: 1546-0096